Original Article

Journal of Investigative Dermatology (1979) 73, 575–581; doi:10.1111/1523-1747.ep12541618

Appearance of "Pemphigus Acantholysis Factor" in Human Skin Cultured with Pemphigus Antibody

John R Schiltz, Beno Michel and Robert Papay

University Hospitals of Cleveland, Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio, U.S.A.

Received 8 January 1979; Accepted 11 July 1979.

Top

Abstract

These studies deal with the mechanism of pemphigus IgG-induced epidermal acantholysis. When normal human skin was cultured with defined medium containing IgG from pemphigus serum, extensive epidermal acantholysis developed and heat-labile proteolytic enzyme(s) were recovered in the culture medium. The enzyme(s) displayed maximal activity at pH 6.5 when a 3H-amino acid-labeled, insoluble epidermal cell material was used as substrate. The enzyme activity increased during the first 3 days of culture and the appearance of maximal activity coincided with the time of onset of acantholysis. Acantholysis did not occur in control cultures incubated with normal IgG and the enzyme did not appear in the medium or in aqueous extracts of cultured tissues. The enzyme(s) is probably not of lysosomal origin because low pH-active proteases characteristic of these organelles remained within the cells. The effects of puromycin on appearance of enzyme activity, acantholysis and cell viability was studied. At cytotoxic concentrations, the appearance of the enzyme(s) and acantholysis were prevented, whereas at less toxic concentrations enzyme activity and acantholysis were not prevented. Because inhibition of protein synthetic rates by puromycin could not be dissociated from the cytotoxic effects, it is uncertain whether enzyme appearance and acantholysis were dependent upon living tissue or on specific protein synthesis. After pemphigus IgG was removed from the conditioned medium by DEAE cellulose and affinity column chromatography, the remaining material contained enzyme activity and caused acantholysis in fresh skin explants. Similar activities were not present in normal IgG-containing conditioned medium or unfractionated epidermal extracts from normal skin. These data indicate that when the pemphigus IgG autoantibody interacts with epidermal cell surface antigens, the cell responds by synthesis or activation of a non-IgG "pemphigus acantholysis factor" (PAF) which may be a nonlysosomal proteolytic enzyme. It is suggested that PAF causes loss of adhesion between keratinocytes and utimately produces the characteristic acantholytic cell of pemphigus.

Top

References

  1. Bellone, A, Leone, V: Ricerche sull'influenze esercitata da sieri di soggetti sani o affetti da pemfigo su pelle umana normale e pemfigosa coltivata "in vitro". G Ital Dermatol Sifilol 1956 97: 97–109,  | ChemPort |
  2. Michel, B, Ko, C: Effect of pemphigus or bullous pemphigoid sera and leukocytes on normal skin in organ culture. An in vitro model for the study of bullous diseases (abstract). J Invest Dermatol 1974 62: 541,
  3. Michel, B, Ko, C: An organ culture model for the study of pemphigus acantholysis. Br J Dermatol 1977 96: 295–302,  | PubMed | ChemPort |
  4. Ruocco, V, Rossi, A, Argenziano, G, Astarita, C, Alviggi, L, Farzati, B, Papaleo, G: Pathogenicity of the intercellular antibodies of pemphigus and their periodic removal from the circulation by plasmapheresis. Br J Dermatol 1978 98: 237–241,  | PubMed | ChemPort |
  5. Deng, J, Beutner, E, Shu, J, Chorzelski, T: Pemphigus antibody action on skin expiants. Kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin expiants. Arch Dermatol 1977 113: 923–926,  | Article | PubMed | ChemPort |
  6. Barnett, M, Beutner, E, Chorzelski, T: Organ culture studies of pemphigus antibodies. Ultrastructural comparison between acantholytic changes in vitro and human pemphigus lesions. J Invest Dermatol 1977 68: 265–271,  | Article | PubMed | ISI | ChemPort |
  7. Schiltz, J, Michel, B: Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 1976 67: 254–260,  | Article | PubMed | ISI | ChemPort |
  8. Hu, C, Michel, B, Schiltz, J: Epidermal acantholysis induced in vitro by pemphigus autoantibody: An ultrastructural study. Am J Pathol 1978 90: 345–362,  | PubMed | ISI | ChemPort |
  9. Schiltz, J, Michel, B, Papay, R: Pemphigus antibody interaction with human epidermal cells in culture. A proposed mechanism for pemphigus acantholysis. J Clin Invest 1978 62: 778–788,  | PubMed | ChemPort |
  10. Pharmacia Fine Chemicals Brochure Affinity Chromatography. Principles and Methods 1974 Rahms i Lund, Sweden,
  11. Hambrick, G. Jr, Blank, H: Whole mounts for the study of skin and its appendages. J Invest Dermatol 1954 23: 437–453,  | PubMed | ISI |
  12. Scott, A: A study on the action of chymotrypsin on the skin. J Invest Dermatol 1958 30: 201–205,  | PubMed | ChemPort |
  13. Stoughton, R, Bagatell, F: The nature of cantharidin acantholysis. J Invest Dermatol 1959 33: 287–292,  | PubMed | ChemPort |
  14. Farb, R, Dykes, R, Lazarus, G: Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci USA 1978 75: 459–463,  | Article | PubMed | ChemPort |
  15. Schiltz, J, Hu, C, Michel, B: Corticosteroids, aurothioglucose and soybean trypsin inhibitor do not prevent pemphigus antibody-induced acantholysis in vitro. Br J Dermatol 101: in press
  16. Drachmen, D: Myasthenia gravis. New Engl J Med 1978 298: 136–142,  | PubMed |
  17. Kao, I, Drachman, D: Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science 1977 196: 527,  | PubMed | ISI | ChemPort |
  18. Stoughton, R, Novak, N: Disruption of tonofibrile and intercellular bridges by disulfide-splitting agents. J Invest Dermatol 1956 26: 127–136,  | PubMed | ChemPort |
  19. Bagatell, F, Stoughton, R: Vesication and acantholysis. The Epidermis 1964 Edited by W Mongagna, W. Lobitz. Acad. Press, New York and London, 601–611,
  20. Elias, P, Fritsch, P, Epstein, E: Staphylococcal scalded skin syndrome. Clinical features, pathogenesis and recent microbiological and biochemical developments. Arch Dermatol 113: 207–219, 117  | Article | PubMed | ISI | ChemPort |
  21. Stoughton, R: Disruption of epithelial cells by heat and specific chemical agents. J Invest Dermatol 1956 27: 395–406,  | PubMed | ChemPort |
  22. Wheeler, C, Briggaman, R: Growth of Heroes simplex virus in human skin organ cultures. Proc Soc Expt Biol Med 1996 132: 405–408,

Extra navigation

.
ADVERTISEMENT